FMP
IRWD icon

Financial Management Professionals’s Ironwood Pharmaceuticals IRWD Stock Holding History

Financial Management Professionals’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,508
Closed -$22.8K – 1079
2026
Q1 		$22.8K Buy
+6,508
New +$26.7K ﹤0.01% 380

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Financial Management Professionals's IRWD Position: Q2 2026 in Review

Financial Management Professionals sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 6,508 shares — an estimated $22.8K sold.

Financial Management Professionals first reported a position in IRWD in Q1 2026 and held it in 1 quarter. The position peaked at $22.8K in Q1 2026. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Financial Management Professionals reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Financial Management Professionals sold 6,508 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $22.8K.
  • Financial Management Professionals first reported a position in Ironwood Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Financial Management Professionals's Ironwood Pharmaceuticals position peaked at $22.8K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.